{"id":4424,"date":"2012-10-10T15:46:33","date_gmt":"2012-10-10T15:46:33","guid":{"rendered":"https:\/\/benzifoundation.org\/v-foresight-training-course-2012\/"},"modified":"2012-10-10T15:46:33","modified_gmt":"2012-10-10T15:46:33","slug":"v-foresight-training-course-2012","status":"publish","type":"post","link":"https:\/\/benzifoundation.org\/it\/v-foresight-training-course-2012\/","title":{"rendered":"V Foresight Training Course \u2013 2012"},"content":{"rendered":"<h3>SCIENCE, REGULATION AND BUSINESS IN PHARMACOTHERAPIES: HOW TO SOLVE CONFLICTS AND EXPLOIT SYNERGIES FOR THE BENEFIT OF PATIENTS<\/h3>\n<h4>29 &#8211; 30 September, 2012<br \/>\n<em>Hyatt Regency Warsaw Hotel \u2013 Warsaw (Poland)<\/em><\/h4>\n<p>Fondazione Gianni Benzi, with the support Warsaw Children\u2019s Memorial Health Institute and SIAR (Italian Society for Regulatory Affairs), organized the V Foresight Training Course. The Course focused on the current controversies in the field of <strong>pharmacological therapies<\/strong> and discuss possible different solutions. <\/p>\n<p>It brought together stakeholders from 12 countries to discuss clinical trials, timely therapy availability, and pricing\/reimbursement of medicines.<\/p>\n<p>Key topics included:<\/p>\n<ol>\n<li><strong>Clinical Trials<\/strong>: A new EU regulation aimed at streamlining the approval process through a single authorization, while reducing bureaucratic impact based on trial risk levels. Concerns about patient protection, especially for vulnerable groups, were raised. <\/li>\n<li><strong>Therapy Availability<\/strong>: Adaptive licensing, allowing drugs to be used based on evolving clinical data, was discussed as a solution for faster access, with examples like gene therapy.<\/li>\n<li><strong>Pricing and Reimbursement<\/strong>: The need to revise the European Transparency Directive was highlighted, aiming for more shared practices across countries to ensure quicker drug availability and fair pricing.<\/li>\n<li><strong>Health Technology Assessment (HTA)<\/strong>: The role of HTA in balancing scientific, ethical, and economic factors was emphasized as a way to offer fairer solutions for citizens.<\/li>\n<\/ol>\n<p>The course included four sessions on pricing, clinical trials, pediatric drug development, and strategies for quicker access to life-saving medicines, all aiming to improve patient access and innovation in Europe.<\/p>\n<p><a href=\"https:\/\/www.benzifoundation.org\/wp-content\/uploads\/2019\/11\/VFTC_Brochure.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Download the brochure of the V FTC<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Science, regulation and business in pharmacotherapies: how to solve conflicts and exploit synergies for the benefit of patients<\/p>\n","protected":false},"author":1,"featured_media":4414,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[220],"tags":[],"class_list":["post-4424","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-foresight"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>V Foresight Training Course \u2013 2012 - Fondazione Gianni Benzi - ETS<\/title>\n<meta name=\"description\" content=\"The V FTC of Fondazione Gianni Benzi addressed pharmacological therapy issues, clinical trials, pricing, and quick drug access.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/benzifoundation.org\/it\/v-foresight-training-course-2012\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"V Foresight Training Course \u2013 2012 - Fondazione Gianni Benzi - ETS\" \/>\n<meta property=\"og:description\" content=\"The V FTC of Fondazione Gianni Benzi addressed pharmacological therapy issues, clinical trials, pricing, and quick drug access.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/benzifoundation.org\/it\/v-foresight-training-course-2012\/\" \/>\n<meta property=\"og:site_name\" content=\"Fondazione Gianni Benzi - ETS\" \/>\n<meta property=\"article:published_time\" content=\"2012-10-10T15:46:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/benzifoundation.org\/wp-content\/uploads\/2026\/01\/FTC-cover-8.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"1000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/v-foresight-training-course-2012\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/v-foresight-training-course-2012\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/#\\\/schema\\\/person\\\/b927dbd45f2d82849380299ff732c266\"},\"headline\":\"V Foresight Training Course \u2013 2012\",\"datePublished\":\"2012-10-10T15:46:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/v-foresight-training-course-2012\\\/\"},\"wordCount\":247,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/v-foresight-training-course-2012\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/benzifoundation.org\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/FTC-cover-8.jpg\",\"articleSection\":[\"Foresight\"],\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/benzifoundation.org\\\/it\\\/v-foresight-training-course-2012\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/v-foresight-training-course-2012\\\/\",\"url\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/v-foresight-training-course-2012\\\/\",\"name\":\"V Foresight Training Course \u2013 2012 - Fondazione Gianni Benzi - ETS\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/v-foresight-training-course-2012\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/v-foresight-training-course-2012\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/benzifoundation.org\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/FTC-cover-8.jpg\",\"datePublished\":\"2012-10-10T15:46:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/#\\\/schema\\\/person\\\/b927dbd45f2d82849380299ff732c266\"},\"description\":\"The V FTC of Fondazione Gianni Benzi addressed pharmacological therapy issues, clinical trials, pricing, and quick drug access.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/v-foresight-training-course-2012\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/benzifoundation.org\\\/it\\\/v-foresight-training-course-2012\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/v-foresight-training-course-2012\\\/#primaryimage\",\"url\":\"https:\\\/\\\/benzifoundation.org\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/FTC-cover-8.jpg\",\"contentUrl\":\"https:\\\/\\\/benzifoundation.org\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/FTC-cover-8.jpg\",\"width\":1200,\"height\":1000},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/v-foresight-training-course-2012\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"V Foresight Training Course \u2013 2012\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/#website\",\"url\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/\",\"name\":\"Fondazione Gianni Benzi - ETS\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/#\\\/schema\\\/person\\\/b927dbd45f2d82849380299ff732c266\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b53d43f1aaeceec75df4938b3e2a7ffb4ca7517db228bbe25ca85e468bfa6e26?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b53d43f1aaeceec75df4938b3e2a7ffb4ca7517db228bbe25ca85e468bfa6e26?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b53d43f1aaeceec75df4938b3e2a7ffb4ca7517db228bbe25ca85e468bfa6e26?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\\\/\\\/benzifoundation.org\"],\"url\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"V Foresight Training Course \u2013 2012 - Fondazione Gianni Benzi - ETS","description":"The V FTC of Fondazione Gianni Benzi addressed pharmacological therapy issues, clinical trials, pricing, and quick drug access.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/benzifoundation.org\/it\/v-foresight-training-course-2012\/","og_locale":"it_IT","og_type":"article","og_title":"V Foresight Training Course \u2013 2012 - Fondazione Gianni Benzi - ETS","og_description":"The V FTC of Fondazione Gianni Benzi addressed pharmacological therapy issues, clinical trials, pricing, and quick drug access.","og_url":"https:\/\/benzifoundation.org\/it\/v-foresight-training-course-2012\/","og_site_name":"Fondazione Gianni Benzi - ETS","article_published_time":"2012-10-10T15:46:33+00:00","og_image":[{"width":1200,"height":1000,"url":"https:\/\/benzifoundation.org\/wp-content\/uploads\/2026\/01\/FTC-cover-8.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Scritto da":"admin","Tempo di lettura stimato":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/benzifoundation.org\/it\/v-foresight-training-course-2012\/#article","isPartOf":{"@id":"https:\/\/benzifoundation.org\/it\/v-foresight-training-course-2012\/"},"author":{"name":"admin","@id":"https:\/\/benzifoundation.org\/it\/#\/schema\/person\/b927dbd45f2d82849380299ff732c266"},"headline":"V Foresight Training Course \u2013 2012","datePublished":"2012-10-10T15:46:33+00:00","mainEntityOfPage":{"@id":"https:\/\/benzifoundation.org\/it\/v-foresight-training-course-2012\/"},"wordCount":247,"commentCount":0,"image":{"@id":"https:\/\/benzifoundation.org\/it\/v-foresight-training-course-2012\/#primaryimage"},"thumbnailUrl":"https:\/\/benzifoundation.org\/wp-content\/uploads\/2026\/01\/FTC-cover-8.jpg","articleSection":["Foresight"],"inLanguage":"it-IT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/benzifoundation.org\/it\/v-foresight-training-course-2012\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/benzifoundation.org\/it\/v-foresight-training-course-2012\/","url":"https:\/\/benzifoundation.org\/it\/v-foresight-training-course-2012\/","name":"V Foresight Training Course \u2013 2012 - Fondazione Gianni Benzi - ETS","isPartOf":{"@id":"https:\/\/benzifoundation.org\/it\/#website"},"primaryImageOfPage":{"@id":"https:\/\/benzifoundation.org\/it\/v-foresight-training-course-2012\/#primaryimage"},"image":{"@id":"https:\/\/benzifoundation.org\/it\/v-foresight-training-course-2012\/#primaryimage"},"thumbnailUrl":"https:\/\/benzifoundation.org\/wp-content\/uploads\/2026\/01\/FTC-cover-8.jpg","datePublished":"2012-10-10T15:46:33+00:00","author":{"@id":"https:\/\/benzifoundation.org\/it\/#\/schema\/person\/b927dbd45f2d82849380299ff732c266"},"description":"The V FTC of Fondazione Gianni Benzi addressed pharmacological therapy issues, clinical trials, pricing, and quick drug access.","breadcrumb":{"@id":"https:\/\/benzifoundation.org\/it\/v-foresight-training-course-2012\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/benzifoundation.org\/it\/v-foresight-training-course-2012\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/benzifoundation.org\/it\/v-foresight-training-course-2012\/#primaryimage","url":"https:\/\/benzifoundation.org\/wp-content\/uploads\/2026\/01\/FTC-cover-8.jpg","contentUrl":"https:\/\/benzifoundation.org\/wp-content\/uploads\/2026\/01\/FTC-cover-8.jpg","width":1200,"height":1000},{"@type":"BreadcrumbList","@id":"https:\/\/benzifoundation.org\/it\/v-foresight-training-course-2012\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/benzifoundation.org\/it\/"},{"@type":"ListItem","position":2,"name":"V Foresight Training Course \u2013 2012"}]},{"@type":"WebSite","@id":"https:\/\/benzifoundation.org\/it\/#website","url":"https:\/\/benzifoundation.org\/it\/","name":"Fondazione Gianni Benzi - ETS","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/benzifoundation.org\/it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Person","@id":"https:\/\/benzifoundation.org\/it\/#\/schema\/person\/b927dbd45f2d82849380299ff732c266","name":"admin","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/secure.gravatar.com\/avatar\/b53d43f1aaeceec75df4938b3e2a7ffb4ca7517db228bbe25ca85e468bfa6e26?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b53d43f1aaeceec75df4938b3e2a7ffb4ca7517db228bbe25ca85e468bfa6e26?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b53d43f1aaeceec75df4938b3e2a7ffb4ca7517db228bbe25ca85e468bfa6e26?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/benzifoundation.org"],"url":"https:\/\/benzifoundation.org\/it\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/benzifoundation.org\/it\/wp-json\/wp\/v2\/posts\/4424","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/benzifoundation.org\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/benzifoundation.org\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/benzifoundation.org\/it\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/benzifoundation.org\/it\/wp-json\/wp\/v2\/comments?post=4424"}],"version-history":[{"count":0,"href":"https:\/\/benzifoundation.org\/it\/wp-json\/wp\/v2\/posts\/4424\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/benzifoundation.org\/it\/wp-json\/wp\/v2\/media\/4414"}],"wp:attachment":[{"href":"https:\/\/benzifoundation.org\/it\/wp-json\/wp\/v2\/media?parent=4424"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/benzifoundation.org\/it\/wp-json\/wp\/v2\/categories?post=4424"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/benzifoundation.org\/it\/wp-json\/wp\/v2\/tags?post=4424"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}